Læknablaðið - 15.12.2003, Síða 32

FRÆÐIGREINAR / VÖÐVASPENNUTRUFLUN
32. Edwards M, Wood N, Bhatia K. Unusual Phenotypes in
DYTl Dystonia: A Report of Five Cases and a Review of the
Literature. Mov Disord 2003; 18: 706-11.
33. Graeber MB, Kupke KG, Míiller U. Delineation of the dys-
tonia-parkinsonism syndrome locus in Xql3. Proc Natl Acad
Sci USA 1992; 89: 8245-824.
34. Ahmad F, Davis MB, Waddy HM, Oley CA, Marsden CD,
Harding AE. Evidence for locus heterogeneity in autosomal
dominant torsion dystonia. Genomics 1992; 15: 9-12.
35. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M,
et al. Hereditary progressive dystonia with marked diurnal
fluctuations caused by mutations in the GTP cyclohydrolase I
gene. Nat Genet 1994; 8: 236-42.
36. Knappskog P, Flatmark T, Mallet J, Ludecke B, Bartholome
K. Recessively inherited L-DOPA-responsive dystonia caused
by a point mutation (Q381K) in the tyrosine hydroxylase gene.
Hum Mol Genet 1995; 4:1209-12.
37. Almasy L, Bressman SB, Raymond D, Kramer PL, Greene
PE, Heiman GA, et al. Idiopathic torsion dystonia linked to
chromosome 8 in two Mennonite families. Ann Neurol 1997;
42: 670-3.
38. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R,
Auburger G. Idiopathic torsion dystonia: assignment of a gene
to chromosome 18p in a German family with adult onset, auto-
somal dominant inheritance and purely focal distribution.
Hum Mol Genet 1996; 5:1673-7.
39. Fouad GT, Servidei S, Simon D, Bertini E, Ptacek LJ. A gene
for familial paroxysmal dyskinesia (FDPl) maps to chromo-
some 2q. Am J Hum Genet 1996; 59:135-9.
40. Auburger G, Ratzlaff T, Lunkes A, Nelles HW, Leube B,
Binkfoski F, et al. A gene for autosomal dominant paroxysmal
choreoathetosis/spasticity (CSE) maps to the vicinity of potas-
sium channel gene cluster on chromosome lp, probably within
2 cM between D1S443 and D1S197. Genomics 1996; 31: 90-4.
41. Tomita H, Nagamitsu S, Wakui K, Fukushima Y, Yamada K,
Sadamatsu M, et al. Paroxysmal kinesigenic choreoathetosis
locus maps to chromosome 16pll,2-ql2.1. Am J Hum Genet
1999; 65:1688-97.
42. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D,
Bertram M, et al. Mutations in the gene encoding epsilon-
sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet
2001; 29: 66-9.
43. Kramer PL, Mineta M, Klein C, Schilling K, de Leon D, Far-
low MR, et al. Rapid-onset dystonia-parkinsonism: iinkage to
chromosome 19ql3. Ann Neurol 1999; 46:176-82.
44. Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis
MB, Ferraris A, et al. Dytl3, a novel primary torsion dystonia
locus, maps to chromosome lp36.13-36.32 in an Italian family
with cranial-cervical or upper limb onset. Ann Neurol 2001;
49: 362-6.
45. Grötzsch H, Pizzolato GP, Ghika J, Schorderet D, Vingerhoets
FJ, Landis T, et al. Neuropathology of a case of dopa-respon-
sive dystonia associated with a new genetic locus, DYT14.
Neurology 2002; 58:1839-42.
46. Richter A, Löscher W. Pathophysiology of idiopathic dysto-
nia: findings from genetic animal models. Prog Neurobiol
1999; 54: 633-77.
47. Berardelli A, Curra A. Pathophysiology and treatment of
cranial dystonia. Mov Disord 2002; 17: 70-4.
48. Hallett M. Disorder of movement preparation in dystonia.
Brain 2000; 122:1765-6.
49. Hummel SM, Líicking CH. Die posttraumatische Dystonie.
Ein Uberblick und gutachterliche Aspekte. Nervenarzt 2001;
72: 93-9.
50. Velickovic M, Benabou R, Brin MF. Cervical dystonia patho-
physiology and treatment options. Drugs 2001; 61:1921-43.
51. Huang W, Foster JA, Rogachefsky AS. Pharmacology of
botulinum toxin. J Am Acad Dermatol 2000; 43: 249-59.
52. Jankovic J, Tintner R. Botulinum toxin for the treatment of
cervical dystonia. Expert Opin Pharmacother 2001; 2:1985-94.
53. Vesper J, Klostermann F, Funk T, Bock M. [Chronic high fre-
quency deep brain stimulation of the globus pallidus internus
for torsion dystonia]. Zentralbl Neurochir 2002; 63:18-22.
54. Hoffman RE, Cavus I. Slow transcranial magnetic stimulation,
long-term depotentiation, and brain hyperexcitability disor-
ders. Am J Psychiatry 2002; 159:1093-102.

948 Læknablaðið 2003/89